ZBH
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc historical holders
total: 14
Viking Global Investors Zimmer Biomet Holdings Inc transactions over time
- Total transactions:
- 13
- New positions:
- 4
- Sold out:
- 4
- Added:
- 2
- Reduced:
- 3
- Held since:
- 2020 Q3
- Held for:
- 6 quarters
- Latest activity:
- 2022 Q1
Ole Andreas Halvorsen has been an institutional investor in Zimmer Biomet Holdings Inc (ZBH) since 2014 Q2. According to 2026 Q1 report, Ole Andreas Halvorsen doesn't hold any shares. The fund/company first acquired ZBH in 2014 Q2, initially purchasing 603,193 shares. Ole Andreas Halvorsen later completely sold out the position and reinvested in ZBH again in 2020 Q3. Since the initial investment, Viking Global Investors has made 12 more transactions in this position.
When did Ole Andreas Halvorsen exit their ZBH position?
Ole Andreas Halvorsen no longer holds Zimmer Biomet Holdings Inc (ZBH). They sold off their entire position in 2022 Q1, closing out an investment that began in 2014 Q2.
When did Ole Andreas Halvorsen first invest in ZBH?
Ole Andreas Halvorsen first invested in Zimmer Biomet Holdings Inc (ZBH) in 2014 Q2 at the reported quarter-end price of $103.86 per share, acquiring 603,193 shares in their initial purchase.
What is Ole Andreas Halvorsen's average cost basis for ZBH?
Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for Zimmer Biomet Holdings Inc (ZBH) is approximately $146.26 per share. This represents their average reported price* across all buy transactions.
Has Ole Andreas Halvorsen reinvested in ZBH after selling?
Yes, Ole Andreas Halvorsen has shown renewed interest in Zimmer Biomet Holdings Inc (ZBH). After completely selling their position, they reinitiated an investment in 2020 Q3, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $146.26
- Weighted AVG sell price:
- $134.17
ZBH transactions history by Viking Global Investors
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q1
|
0.00%
|
0
|
$127.04
|
|
-100% (-2,496,245)
|
-0.91%
|
|
2021 Q4
|
0.91%
|
2,496,245
|
$127.04
|
$317,123,000
|
-26.78% (-912,828)
|
-0.32%
|
|
2021 Q3
|
1.37%
|
3,409,073
|
$146.36
|
$498,952,000
|
+15.40% (+454,902)
|
+0.18%
|
|
2021 Q2
|
1.44%
|
2,954,171
|
$160.82
|
$475,090,000
|
-22.69% (-866,800)
|
-0.42%
|
|
2021 Q1
|
1.82%
|
3,820,971
|
$160.08
|
$611,661,000
|
-1.19% (-46,103)
|
-0.02%
|
|
2020 Q4
|
1.64%
|
$154.09
|
+128.81% (+2,176,989)
|
|||
|
2020 Q3
|
0.83%
|
$136.14
|
new
|
|||
|
2019 Q2
|
0.00%
|
$127.70
|
-100% (-521,466)
|
|||
|
2019 Q1
|
0.38%
|
$127.70
|
new
|
|||
|
2017 Q3
|
0.00%
|
$128.40
|
-100% (-397,654)
|
|||
|
2017 Q2
|
0.34%
|
$128.40
|
new
|
|||
|
2014 Q3
|
0.00%
|
$103.86
|
-100% (-603,193)
|
|||
|
2014 Q2
|
0.27%
|
$103.86
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.